APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Capecitabine

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blood cell counts. It is not recommended in people with kidney problems. Use during pregnancy may result in harm to the baby. Capecitabine, inside the body, is converted to 5-fluorouracil (5-FU) through which it acts. It belongs to the class of medications known as fluoropyrimidines, which also includes 5-fluorouracil and tegafur.

Selected research

Industry Growth & Trends

Global Capecitabine Industry Growth and Trends Forecast to 2032

Report ID 173974640121 December 202593 pages

Choose your research edition.

Industry ResearchCapecitabine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Capecitabine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Capecitabine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Capecitabine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Capecitabine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blood cell counts. It is not recommended in people with kidney problems. Use during pregnancy may result in harm to the baby. Capecitabine, inside the body, is converted to 5-fluorouracil (5-FU) through which it acts. It belongs to the class of medications known as fluoropyrimidines, which also includes 5-fluorouracil and tegafur.

Roche, Teva and Mylan are the top 3 of Capecitabine, with about 87% market shares.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Capecitabine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Capecitabine market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Capecitabine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant toCapecitabine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Capecitabine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Capecitabine Market by Company

Roche

Teva

Mylan

Hikma

Hengrui Medicine

Cipla

Reliance Group

Hetero

Capecitabine Segment by Type

500 mg

150 mg

Capecitabine Segment by Application

Breast Cancer

Colorectal Cancer

Stomach Cancer

Capecitabine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Capecitabine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Capecitabine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Capecitabine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Capecitabine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Capecitabine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 500 mg Table 2. Major Company of 150 mg Table 3. Global Capecitabine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Capecitabine Sales by Type (2021-2026) & (Kg) Table 5. Global Capecitabine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Capecitabine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Capecitabine Sales Market Share in Value by Type (2021-2026) Table 8. Global Capecitabine Price by Type (2021-2026) & (USD/g) Table 9. Global Capecitabine Sales by Type (2027-2032) & (Kg) Table 10. Global Capecitabine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Capecitabine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Capecitabine Sales Market Share in Value by Type (2027-2032) Table 13. Global Capecitabine Price by Type (2027-2032) & (USD/g) Table 14. North America Capecitabine Sales by Type (2021-2026) & (Kg) Table 15. North America Capecitabine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Capecitabine Sales by Type (2021-2026) & (Kg) Table 17. Europe Capecitabine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Capecitabine Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Capecitabine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Capecitabine Sales by Type (2021-2026) & (Kg) Table 21. Latin America Capecitabine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Capecitabine Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Capecitabine Sales by Type (2021-2026) & (US$ Million) Table 24. Capecitabine Industry Trends Table 25. Capecitabine Industry Drivers Table 26. Capecitabine Industry Opportunities and Challenges Table 27. Capecitabine Industry Restraints Table 28. Global Capecitabine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Capecitabine Revenue Market Share by Company (2021-2026) Table 30. Global Capecitabine Sales by Company (2021-2026) & (Kg) Table 31. Global Capecitabine Sales Share by Company (2021-2026) Table 32. Global Capecitabine Market Price by Company (2021-2026) & (USD/g) Table 33. Global Capecitabine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Capecitabine Major Company Production Sites and Headquarters Table 35. Global Capecitabine Company, Product Type & Application Table 36. Global Capecitabine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Capecitabine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Capecitabine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Capecitabine Sales by Region (2021-2026) & (Kg) Table 41. Global Capecitabine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Capecitabine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Capecitabine Sales Market Share in Value by Region (2021-2026) Table 44. Global Capecitabine Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 45. Global Capecitabine Sales by Region (2027-2032) & (Kg) Table 46. Global Capecitabine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Capecitabine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Capecitabine Sales Market Share in Value by Region (2027-2032) Table 49. Global Capecitabine Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2027-2032) Table 50. Global Capecitabine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Capecitabine Sales by Application (2021-2026) & (Kg) Table 52. Global Capecitabine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Capecitabine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Capecitabine Sales Market Share in Value by Application (2021-2026) Table 55. Global Capecitabine Price by Application (2021-2026) & (USD/g) Table 56. Global Capecitabine Sales by Application (2027-2032) & (Kg) Table 57. Global Capecitabine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Capecitabine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Capecitabine Sales Market Share in Value by Application (2027-2032) Table 60. Global Capecitabine Price by Application (2027-2032) & (USD/g) Table 61. North America Capecitabine Sales by Application (2021-2026) & (Kg) Table 62. North America Capecitabine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Capecitabine Sales by Application (2021-2026) & (Kg) Table 64. Europe Capecitabine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Capecitabine Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Capecitabine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Capecitabine Sales by Application (2021-2026) & (Kg) Table 68. Latin America Capecitabine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Capecitabine Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Capecitabine Sales by Application (2021-2026) & (US$ Million) Table 71. Roche Company Information Table 72. Roche Business Overview Table 73. Roche Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 74. Roche Capecitabine Product Portfolio Table 75. Roche Recent Development Table 76. Teva Company Information Table 77. Teva Business Overview Table 78. Teva Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 79. Teva Capecitabine Product Portfolio Table 80. Teva Recent Development Table 81. Mylan Company Information Table 82. Mylan Business Overview Table 83. Mylan Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 84. Mylan Capecitabine Product Portfolio Table 85. Mylan Recent Development Table 86. Hikma Company Information Table 87. Hikma Business Overview Table 88. Hikma Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 89. Hikma Capecitabine Product Portfolio Table 90. Hikma Recent Development Table 91. Hengrui Medicine Company Information Table 92. Hengrui Medicine Business Overview Table 93. Hengrui Medicine Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 94. Hengrui Medicine Capecitabine Product Portfolio Table 95. Hengrui Medicine Recent Development Table 96. Cipla Company Information Table 97. Cipla Business Overview Table 98. Cipla Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 99. Cipla Capecitabine Product Portfolio Table 100. Cipla Recent Development Table 101. Reliance Group Company Information Table 102. Reliance Group Business Overview Table 103. Reliance Group Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 104. Reliance Group Capecitabine Product Portfolio Table 105. Reliance Group Recent Development Table 106. Hetero Company Information Table 107. Hetero Business Overview Table 108. Hetero Capecitabine Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 109. Hetero Capecitabine Product Portfolio Table 110. Hetero Recent Development Table 111. North America Capecitabine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 112. North America Capecitabine Sales by Country (2021-2026) & (Kg) Table 113. North America Capecitabine Sales Market Share by Country (2021-2026) Table 114. North America Capecitabine Sales Forecast by Country (2027-2032) & (Kg) Table 115. North America Capecitabine Sales Market Share Forecast by Country (2027-2032) Table 116. North America Capecitabine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Capecitabine Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Capecitabine Market Share by Country (2021-2026) Table 119. North America Capecitabine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Capecitabine Market Share Forecast by Country (2027-2032) Table 121. Europe Capecitabine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 122. Europe Capecitabine Sales by Country (2021-2026) & (Kg) Table 123. Europe Capecitabine Sales Market Share by Country (2021-2026) Table 124. Europe Capecitabine Sales Forecast by Country (2027-2032) & (Kg) Table 125. Europe Capecitabine Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Capecitabine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Capecitabine Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Capecitabine Market Share by Country (2021-2026) Table 129. Europe Capecitabine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Capecitabine Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Capecitabine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Capecitabine Sales by Country (2021-2026) & (Kg) Table 133. Asia-Pacific Capecitabine Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Capecitabine Sales Forecast by Country (2027-2032) & (Kg) Table 135. Asia-Pacific Capecitabine Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Capecitabine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Capecitabine Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Capecitabine Market Share by Country (2021-2026) Table 139. Asia-Pacific Capecitabine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Capecitabine Market Share Forecast by Country (2027-2032) Table 141. Latin America Capecitabine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 142. Latin America Capecitabine Sales by Country (2021-2026) & (Kg) Table 143. Latin America Capecitabine Sales Market Share by Country (2021-2026) Table 144. Latin America Capecitabine Sales Forecast by Country (2027-2032) & (Kg) Table 145. Latin America Capecitabine Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Capecitabine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Capecitabine Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Capecitabine Market Share by Country (2021-2026) Table 149. Latin America Capecitabine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Capecitabine Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Capecitabine Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Capecitabine Sales by Country (2021-2026) & (Kg) Table 153. Middle East and Africa Capecitabine Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Capecitabine Sales Forecast by Country (2027-2032) & (Kg) Table 155. Middle East and Africa Capecitabine Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Capecitabine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Capecitabine Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Capecitabine Market Share by Country (2021-2026) Table 159. Middle East and Africa Capecitabine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Capecitabine Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Capecitabine Distributors List Table 164. Capecitabine Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Capecitabine Image Figure 2. Global Capecitabine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Capecitabine Market Size (2021-2032) & (US$ Million) Figure 4. Global Capecitabine Sales (2021-2032) & (Kg) Figure 5. 500 mg Image Figure 6. Global 500 mg Sales YoY Growth (2021-2032) & (Kg) Figure 7. 150 mg Image Figure 8. Global 150 mg Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Capecitabine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Capecitabine Market Share by Type 2025 VS 2032 Figure 11. North America Capecitabine Sales Market Share in Volume by Type in 2025 Figure 12. North America Capecitabine Sales Market Share in Value by Type in 2025 Figure 13. Europe Capecitabine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Capecitabine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Capecitabine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Capecitabine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Capecitabine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Capecitabine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Capecitabine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Capecitabine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Capecitabine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Breast Cancer Image Figure 24. Global Breast Cancer Sales YoY Growth (2021-2032) & (Kg) Figure 25. Colorectal Cancer Image Figure 26. Global Colorectal Cancer Sales YoY Growth (2021-2032) & (Kg) Figure 27. Stomach Cancer Image Figure 28. Global Stomach Cancer Sales YoY Growth (2021-2032) & (Kg) Figure 29. Global Capecitabine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Capecitabine Market Share by Application 2025 VS 2032 Figure 31. North America Capecitabine Sales Market Share in Volume by Application in 2025 Figure 32. North America Capecitabine Sales Market Share in Value by Application in 2025 Figure 33. Europe Capecitabine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Capecitabine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Capecitabine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Capecitabine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Capecitabine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Capecitabine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Capecitabine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Capecitabine Sales Market Share in Value by Application in 2025 Figure 41. North America Capecitabine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 42. North America Capecitabine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Capecitabine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Capecitabine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Capecitabine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 46. Europe Capecitabine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Capecitabine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Capecitabine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Capecitabine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 50. Asia-Pacific Capecitabine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Capecitabine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Capecitabine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Capecitabine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 54. Latin America Capecitabine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Capecitabine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Capecitabine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Capecitabine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 58. Middle East and Africa Capecitabine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Capecitabine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Capecitabine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Capecitabine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Capecitabine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 500 mg
  • 150 mg
Applications
  • Breast Cancer
  • Colorectal Cancer
  • Stomach Cancer
Companies covered
  • Roche
  • Teva
  • Mylan
  • Hikma
  • Hengrui Medicine
  • Cipla
  • Reliance Group
  • Hetero

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Capecitabine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Capecitabine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Capecitabine Market by Type
  6. 1.3.1 500 mg
  7. 1.3.2 150 mg
  8. 1.4 Global Capecitabine Market Size by Type
  9. 1.4.1 Global Capecitabine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Capecitabine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Capecitabine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Capecitabine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Capecitabine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Capecitabine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Capecitabine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Capecitabine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Capecitabine Industry Trends
  2. 2.2 Capecitabine Industry Drivers
  3. 2.3 Capecitabine Industry Opportunities and Challenges
  4. 2.4 Capecitabine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Capecitabine Revenue (2021-2026)
  2. 3.2 Global Top Players by Capecitabine Sales (2021-2026)
  3. 3.3 Global Top Players by Capecitabine Price (2021-2026)
  4. 3.4 Global Capecitabine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Capecitabine Major Company Production Sites & Headquarters
  6. 3.6 Global Capecitabine Company, Product Type & Application
  7. 3.7 Global Capecitabine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Capecitabine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Capecitabine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Capecitabine Tier 1, Tier 2, and Tier 3
4 Capecitabine Regional Status and Outlook
  1. 4.1 Global Capecitabine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Capecitabine Historic Market Size by Region
  3. 4.2.1 Global Capecitabine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Capecitabine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Capecitabine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Capecitabine Forecasted Market Size by Region
  7. 4.3.1 Global Capecitabine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Capecitabine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Capecitabine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Capecitabine by Application
  1. 5.1 Capecitabine Market by Application
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Colorectal Cancer
  4. 5.1.3 Stomach Cancer
  5. 5.2 Global Capecitabine Market Size by Application
  6. 5.2.1 Global Capecitabine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Capecitabine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Capecitabine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Capecitabine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Capecitabine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Capecitabine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Capecitabine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Capecitabine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Capecitabine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Roche Capecitabine Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Capecitabine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Capecitabine Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Capecitabine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Capecitabine Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Hikma
  20. 6.4.1 Hikma Company Information
  21. 6.4.2 Hikma Business Overview
  22. 6.4.3 Hikma Capecitabine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hikma Capecitabine Product Portfolio
  24. 6.4.5 Hikma Recent Developments
  25. 6.5 Hengrui Medicine
  26. 6.5.1 Hengrui Medicine Company Information
  27. 6.5.2 Hengrui Medicine Business Overview
  28. 6.5.3 Hengrui Medicine Capecitabine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hengrui Medicine Capecitabine Product Portfolio
  30. 6.5.5 Hengrui Medicine Recent Developments
  31. 6.6 Cipla
  32. 6.6.1 Cipla Company Information
  33. 6.6.2 Cipla Business Overview
  34. 6.6.3 Cipla Capecitabine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cipla Capecitabine Product Portfolio
  36. 6.6.5 Cipla Recent Developments
  37. 6.7 Reliance Group
  38. 6.7.1 Reliance Group Company Information
  39. 6.7.2 Reliance Group Business Overview
  40. 6.7.3 Reliance Group Capecitabine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Reliance Group Capecitabine Product Portfolio
  42. 6.7.5 Reliance Group Recent Developments
  43. 6.8 Hetero
  44. 6.8.1 Hetero Company Information
  45. 6.8.2 Hetero Business Overview
  46. 6.8.3 Hetero Capecitabine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hetero Capecitabine Product Portfolio
  48. 6.8.5 Hetero Recent Developments
7 North America by Country
  1. 7.1 North America Capecitabine Sales by Country
  2. 7.1.1 North America Capecitabine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Capecitabine Sales by Country (2021-2026)
  4. 7.1.3 North America Capecitabine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Capecitabine Market Size by Country
  6. 7.2.1 North America Capecitabine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Capecitabine Market Size by Country (2021-2026)
  8. 7.2.3 North America Capecitabine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Capecitabine Sales by Country
  2. 8.1.1 Europe Capecitabine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Capecitabine Sales by Country (2021-2026)
  4. 8.1.3 Europe Capecitabine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Capecitabine Market Size by Country
  6. 8.2.1 Europe Capecitabine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Capecitabine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Capecitabine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Capecitabine Sales by Country
  2. 9.1.1 Asia-Pacific Capecitabine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Capecitabine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Capecitabine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Capecitabine Market Size by Country
  6. 9.2.1 Asia-Pacific Capecitabine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Capecitabine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Capecitabine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Capecitabine Sales by Country
  2. 10.1.1 South America Capecitabine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Capecitabine Sales by Country (2021-2026)
  4. 10.1.3 South America Capecitabine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Capecitabine Market Size by Country
  6. 10.2.1 South America Capecitabine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Capecitabine Market Size by Country (2021-2026)
  8. 10.2.3 South America Capecitabine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Capecitabine Sales by Country
  2. 11.1.1 Middle East and Africa Capecitabine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Capecitabine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Capecitabine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Capecitabine Market Size by Country
  6. 11.2.1 Middle East and Africa Capecitabine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Capecitabine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Capecitabine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Capecitabine Value Chain Analysis
  2. 12.1.1 Capecitabine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Capecitabine Production Mode & Process
  7. 12.2 Capecitabine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Capecitabine Distributors
  10. 12.2.3 Capecitabine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst